Status:
COMPLETED
Estrogen Receptor 1 Gene Polymorphism Frequency in Fibromyalgia Syndrome
Lead Sponsor:
Nigde Omer Halisdemir University
Conditions:
Fibromyalgia
Eligibility:
All Genders
18-60 years
Brief Summary
Fibromyalgia Syndrome (FMS) is a chronic musculoskeletal disorder accompanied by diffuse body pain, increased fatigue and tenderness in specific anatomical regions, and sleep disturbance. The higher p...
Detailed Description
Objective: The fact that fibromyalgia and migraine are more common in women of reproductive age and their incidence are higher than other populations suggests that these three diseases may have a comm...
Eligibility Criteria
Inclusion
- -- As the inclusion criteria for the Fibromyalgia group ;
- Being between 18 and 60 years of age,
- Taking the diagnosis of primary FMS according to ACR 1990 diagnostic criteria,
- Accepting to participate in the study
- As the inclusion criteria for the Control group;
- Being between 18 and 60 years of age,
- Accepting to participate in the study
- No diagnosis of fibromyalgia.
- --
Exclusion
- Having any sex hormone disease
Key Trial Info
Start Date :
March 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03786393
Start Date
March 11 2019
End Date
May 15 2021
Last Update
September 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BOR Physical medicine and rehabilitaton hospital
Niğde, Turkey (Türkiye), 51000